Robin Nijveldt

Robin Nijveldt

Auto-generated profile, based on publicly available information

Robin Nijveldt

Department of Cardiology, Division of Heart and Lungs, University Medical Center Utrecht, Utrecht, The Netherlands

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2023 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
AEArturo Evangelista
Arturo Evangelista
MSMarta Sitges
Marta Sitges
GJGuillaume Jondeau
Guillaume Jondeau
RNRobin Nijveldt
Robin Nijveldt
Mauro PepiMauro Pepi
Mauro Pepi
JRJose Rodríguez-Palomares
Jose Rodríguez-Palomares
Imaging techniques play a pivotal role in the diagnosis, follow-up, and management of aortic diseases. Multimodality imaging provides complementary and essential information for this evaluation. Echocardiography, computed tomography, cardiovascular magnetic resonance, and nuclear imaging each have strengths and limitations in the assessment of the aorta. This consensus document aims to review the contribution, methodology, and indications of each technique for an adequate management of patients with thoracic aortic diseases. The abdominal aorta will be addressed elsewhere. While this document is exclusively focused on imaging, it is of most importance to highlight that regular imaging follow-up in patients with a diseased aorta is also an opportunity to check the patient’s cardiovascular risk factors and particularly blood pressure control.

28 April 2022 in Journal of Cardiovascular Magnetic Resonance
Verified
Journal Article
Open access
PDF file
WHW. Gregory Hundley
W. Gregory Hundley
DBDavid A. Bluemke
David A. Bluemke
BJBogaert Jan
Bogaert Jan
SFScott D. Flamm
Scott D. Flamm
MFMarianna Fontana
Marianna Fontana
ARAlbert van Rossum
Albert van Rossum

1 October 2021 in Radiology
Verified
Journal Article
Closed access
CBCasper W. H. Beijnink
Casper W. H. Beijnink
NHNina W. van der Hoeven
Nina W. van der Hoeven
LKLara S. F. Konijnenberg
Lara S. F. Konijnenberg
RKRaymond J. Kim
Raymond J. Kim
SBSebastiaan C. A. M. Bekkers
Sebastiaan C. A. M. Bekkers
RNRobin Nijveldt
Robin Nijveldt
Although there is strong histologic evidence for cardiac MRI–defined myocardial infarction characteristics such as infarct size, edema, microvascular injury, and replacement fibrosis, relatively ne... Cardiac MRI is a noninvasive diagnostic tool using nonionizing radiation that is widely used in patients with ST-segment elevation myocardial infarction (STEMI). Cardiac MRI depicts different progn...

19 October 2022 in JACC: Cardiovascular Imaging
Verified
Journal Article
Open access
DZDasa Zugwitz
Dasa Zugwitz
KFKenneth Fung
Kenneth Fung
NANay Aung
Nay Aung
ERElisa Rauseo
Elisa Rauseo
CMCeleste McCracken
Celeste McCracken
RNRobin Nijveldt
Robin Nijveldt
Mitral annular disjunction is the atrial displacement of the mural mitral valve leaflet hinge point within the atrioventricular junction. Said to be associated with malignant ventricular arrhythmias and sudden death, its prevalence in the general population is not known. The purpose of this study was to assess the frequency of occurrence and extent of mitral annular disjunction in a large population cohort. The authors assessed the cardiac magnetic resonance (CMR) images in 2,646 Caucasian subjects enrolled in the UK Biobank imaging study, measuring the length of disjunction at 4 points around the mitral annulus, assessing for presence of prolapse or billowing of the leaflets, and for curling motion of the inferolateral left ventricular wall. From 2,607 included participants, the authors found disjunction in 1,990 (76%) cases, most commonly at the anterior and inferior ventricular wall. The authors found inferolateral disjunction, reported as clinically important, in 134 (5%) cases. Prolapse was more frequent in subjects with disjunction (odds ratio [OR]: 2.5; P = 0.02), with positive associations found between systolic curling and disjunction at any site (OR: 3.6; P < 0.01), and systolic curling and prolapse (OR: 71.9; P < 0.01). This large-scale study shows that disjunction is a common finding when using CMR. Disjunction at the inferolateral ventricular wall, however, was rare. The authors found associations between disjunction and both prolapse and billowing of the mural mitral valve leaflet. These findings support the notion that only extensive inferolateral disjunction, when found, warrants consideration of further investigation, but disjunction elsewhere in the annulus should be considered a normal finding.

9 July 2022 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
Sophie I. MavrogeniSophie I. Mavrogeni
Sophie I. Mavrogeni
Alessia PepeAlessia Pepe
Alessia Pepe
RNR Nijveldt
R Nijveldt
NNNtobeko Ntusi
Ntobeko Ntusi
LSLilia Mercedes Sierra-Galan
Lilia Mercedes Sierra-Galan
BCBernard Cosyns
Bernard Cosyns
Autoimmune rheumatic diseases (ARDs) involve multiple organs including the heart and vasculature. Despite novel treatments, patients with ARDs still experience a reduced life expectancy, partly caused by the higher prevalence of cardiovascular disease (CVD). This includes CV inflammation, rhythm disturbances, perfusion abnormalities (ischaemia/infarction), dysregulation of vasoreactivity, myocardial fibrosis, coagulation abnormalities, pulmonary hypertension, valvular disease, and side-effects of immunomodulatory therapy. Currently, the evaluation of CV involvement in patients with ARDs is based on the assessment of cardiac symptoms, coupled with electrocardiography, blood testing, and echocardiography. However, CVD may not become overt until late in the course of the disease, thus potentially limiting the therapeutic window for intervention. More recently, cardiovascular magnetic resonance (CMR) has allowed for the early identification of pathophysiologic structural/functional alterations that take place before the onset of clinically overt CVD. CMR allows for detailed evaluation of biventricular function together with tissue characterization of vessels/myocardium in the same examination, yielding a reliable assessment of disease activity that might not be mirrored by blood biomarkers and other imaging modalities. Therefore, CMR provides diagnostic information that enables timely clinical decision-making and facilitates the tailoring of treatment to individual patients. Here we review the role of CMR in the early and accurate diagnosis of CVD in patients with ARDs compared with other non-invasive imaging modalities. Furthermore, we present a consensus-based decision algorithm for when a CMR study could be considered in patients with ARDs, together with a standardized study protocol. Lastly, we discuss the clinical implications of findings from a CMR examination.

2 August 2017 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
RARaquel P. Amier
Raquel P. Amier
RTRuben Y. G. Tijssen
Ruben Y. G. Tijssen
PTPaul F. A. Teunissen
Paul F. A. Teunissen
RFRodrigo Fernández‐Jiménez
Rodrigo Fernández‐Jiménez
GPGonzalo Pizarro
Gonzalo Pizarro
RNRobin Nijveldt
Robin Nijveldt
Background: Findings from recent studies show that microvascular injury consists of microvascular destruction and intramyocardial hemorrhage ( IMH ). Patients with ST‐segment elevation myocardial infarction ( STEMI ) with IMH show poorer prognoses than patients without IMH . Knowledge on predictors for the occurrence of IMH after STEMI is lacking. The current study aimed to investigate the prevalence and extent of IMH in patients with STEMI and its relation with periprocedural and clinical variables. Methods and Results: A multicenter observational cohort study was performed in patients with successfully reperfused STEMI with cardiovascular magnetic resonance examination 5.5±1.8 days after percutaneous coronary intervention. Microvascular injury was visualized using late gadolinium enhancement and T2‐weighted cardiovascular magnetic resonance imaging for microvascular obstruction and IMH , respectively. The median was used as the cutoff value to divide the study population with presence of IMH into mild or extensive IMH . Clinical and periprocedural parameters were studied in relation to occurrence of IMH and extensive IMH , respectively. Of the 410 patients, 54% had IMH . The presence of IMH was independently associated with anterior infarction (odds ratio, 2.96; 95% CI , 1.73–5.06 [ P <0.001]) and periprocedural glycoprotein II b/ III a inhibitor treatment (odds ratio, 2.67; 95% CI , 1.49–4.80 [ P <0.001]). Extensive IMH was independently associated with anterior infarction (odds ratio, 3.76; 95% CI , 1.91–7.43 [ P <0.001]). Presence and extent of IMH was associated with larger infarct size, greater extent of microvascular obstruction, larger left ventricular dimensions, and lower left ventricular ejection fraction (all P <0.001). Conclusions: Occurrence of IMH was associated with anterior infarction and glycoprotein II b/ III a inhibitor treatment. Extensive IMH was associated with anterior infarction. IMH was associated with more severe infarction and worse short‐term left ventricular function in patients with STEMI.